JPRN-UMIN000004242CompletedPhase 2
eukocytapheresis for Maintenance of Remission in Patients with Refractory Inflammatory Bowel Disease: A single-centre, Randomized, Double Blinded Trial - Leukocytapheresis as Maintenance of Remission in Patients with Inflammatory Bowel Disease
Department of Lower Gastroenterology, Hyogo College of Medicine0 sites30 target enrollmentStarted: September 21, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 12years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria included therapy with cyclosporine, tacrolimus earlier than 4 weeks prior to start study, infliximab earlier than 8 weeks prior to start study. Also, patients with having granulocytopenia (neutrophil count <2,000/micro-liter), serious heart or kidney disease, coagulation disorder, history of hypersensitivity to heparin or heparin-induced thrombocytopenia, hypotension (<90/65mmHg) or uncontrolled hypertension (>180/ 120mmHg, despite medical therapy; anemia lower than 9.0g/dl in hemoglobin, and women being or wishing pregnant, were excluded.
Investigators
Similar Trials
Completed
Phase 2
Plasmapheresis in the treatment of patients with COVID-19coronavirus disease (covid-19).Coronavirus as the cause of diseases classified elsewhereB97.2IRCT20180316039112N3Iran University of Medical Sciences100
Completed
Not Applicable
THE USE OF MELANOCYTE/KERATINOCYTE CO-SUSPENSION FOR THE RE-PIGMENTATION OF AMELANOTIC PATCHES IN VITILIGOVitiligoSkin - Dermatological conditionsACTRN12607000635460Royal Adelaide Hospital15
Active, not recruiting
Phase 1
Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancerEUCTR2016-001865-99-NLCatharina Ziekenhuis358
Recruiting
Phase 3
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone: a multicentre, open-label, parallel-group, phase II-III, randomised superiority study (CAIRO6).Peritoneal metastases of colorectal cancerColon cancer with metastases in the peritoneum100346521001799110017998NL-OMON55637Catharina-ziekenhuis298
Active, not recruiting
Phase 2
se of plasma of cured person to treat patient with severe covid-19Coronavirus infection, transfusion, C23, A00-B99, Coronavirus OC43, Human.A00-B99RBR-7f4mt9fHemocentro de Ribeirão Preto